Migraine headache: Rational polytherapy using dopamine antagonists

Headache Quarterly

Volumn 9, Issue 3, 1998, Pages 237-240

  Peroutka, Stephen J ^a,b  

^a Spectra Biomedical Inc

^b Spectra Biomedical Inc   (United States)

Author keywords

5 HT agonist; Dopamine antagonists; Polytherapy

Indexed keywords

ACETYLSALICYLIC ACID; APOMORPHINE; BROMOCRIPTINE MESILATE; CAFERGOT; DIHYDROERGOCRISTINE; DIHYDROERGOTAMINE MESILATE; DOPAMINE RECEPTOR BLOCKING AGENT; ERGOTAMINE TARTRATE; METOCLOPRAMIDE; PROCHLORPERAZINE MALEATE; RIZATRIPTAN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; WIGRAINE; ZOLMITRIPTAN;

ADULT; ANTIINFLAMMATORY ACTIVITY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INTESTINE ABSORPTION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; REVIEW; STOMACH MOTILITY;

EID: 0031682572     PISSN: 10597565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. McCarthy BG, Peroutka SJ. Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175). Headache 1989; 29:420-422.
2. Peroutka SJ. Sumatriptan in acute migraine: Pharmacology and review of world experience. Headache 1990; 30:554-560.
3. Tfelt-Hansen P. Sumatriptan for the treatment of migraine attacks - A review of controlled clinical trials. Cephalalgia 1993; 13:238-244.
4. 10 receptor agonist in the acute oral treatment of migraine: A double-blind, placebo-controlled, dose-range finding study. Neurology 1996; 46:522-526.
5. Cutler NR, Claghorn J, Sramek JJ, Block G, Panebianco D, Cheng H, et al. Pilot study of MK-462 in migraine. Cephalalgia 1996; 16:113-116.
6. Visser WH, DeVriend RHM, Jaspers NMWH, Ferrari MD. Sumatriptan in clinical practice: A 2-year review of 453 migraine patients. Neurology 1996; 47:46-51.
7. Lance JW. Headache. Ann Neurol 1981; 10:1-10.
8. Wilkinson M. Treatment of the acute migraine attack - Current status. Cephalalgia 1983; 3:61-67.
9. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986; 26:168-171.
10. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1996; 346:923-926.
11. Lance JW, Anthony M. Some clinical aspects of migraine. Arch Neurol 1966; 15:356-361.
12. Olesen J. Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache 1978; 18:268-271.
13. Silberstein SD, Lipton RB, Breslau N. Migraine association with personality characteristics and psychopathology. Cephalalgia 1995; 15:358-369.
14. Russell MB, Rasmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: A study of 484 male and female migraineurs from the general population. Cephalalgia 1996; 16:239-245.
15. International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(suppl 7):1-96.
16. Ison PJ, Peroutka SJ. Neurotransmitter receptor binding predicts antiemetic efficacy and side effects. Cancer Treat Rep 1986; 70:637-641.
17. Kaufman J, Levine I. Acute gastric dilatation of stomach during attack of migraine. Radiology 1963; 27:301-302.
18. Nimmo J, Heading RC, Tothill P, Prescott LF. Pharmacological modification of gastric emptying: Effects of propantheline and metoclopramide on paracetamol absorption. Br Med J 1973; 1:587-589.
19. Nimmo J. The influence of metoclopramide on drug absorption. Postgrad Med J 1973; 49:25-28.
20. Volans GN. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 1975; 2:57-63.
21. Wainscott G, Kaspi T, Volans GN. The influence of thiethylperazine on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 1976; 3:1015-1021.
22. Kreel L. The use of metoclopramide in radiology. Postgrad Med J 1973; 49:42-45.
23. Volans GN. Research review - Migraine and drug absorption. Clin Pharmacokinet 1978; 3:313-318.
24. Volans GN. Absorption of effervescent aspirin during migraine. Br Med J 1974; 4:265-269.
25. Sicuteri F. Dopamine, the second putative protagonist in headache. Headache 1977; 17:129-131.
26. Fanciullacci M, Michelacci S, Curradi C, Sicuteri F. Hyper-responsiveness of migraine patients to the hypotensive action of bromocriptine. Headache 1980; 20:99-102.
27. Bes A, Guell A, Victor G, Bru A, Jauzac P, Geraud G. Effects of a dopaminergic agonist (Piribedil) on CBF in migraine patients. J Cereb Blood Flow Metabol 1981; 1:S549-S550.
28. Sicuteri F, Boccuni M, Fanciullacci M, D'Egidio P, Bonciana M. A new non-vascular interpretation of syncopal migraine. Adv Neurol 1982; 33:199-208.
29. Geraud G, Guell A, Courtade M, Dupui P, Bes A. Clinical value of a dopaminergic agonist administration in migraine patients. Headache 1983; 23:191-192.
30. Montrastruc JL, David J, Rascol A. Does the piribedil test permit predicting the efficacy of domperidone, a dopaminergic antagonist, in the treatment of migraine? Headache 1985; 25:332-333.
31. Bes A Dupui P, Guell A, Bessoles G, Geraud G. Pharmacological exploration of dopamine hypersensitivity in migraine patients, Int J Clin Pharmacol Res 1986; 6:189-192.
32. Murialdo G, Martignoni E, DeMaria A, Bonura ML, Sances G, Bono G, et al. Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine. Cephalalgia 1986; 6:43-49.
33. Sabatini U, Rascol O, Rascol A, Montastruc J. Migraine attacks induced by subcutaneous apomorphine in two migraineur Parkinsonian patients. Clin Neuropharmacol 1990; 13:264-267.
34. Blin O, Azulay J, Masson G, Aubrespey G, Serratrice G. Apomorphine-induced yawning in migraine patients: Enhanced responsiveness. Clin Neuropharmacol 1991; 14:91-95.
35. Piccini P, Pavese N, Palombo C, Pitella G, Distante A, Bonuccelli U. Transcranial doppler ultrasound in migraine and tension-type headache after apomorphine administration: Double-blind crossover versus placebo study. Cephalalgia 1995; 15:399-403.
36. Del Zompo M, Lai M, Loi V, Pisano MR. Dopamine hypersensitivity in migraine: Role in apomorphine syncope. Headache 1995; 35:222-224.
37. 2) Ncol alleles. Neurology 1997; 49:201-206.
38. Peroutka SJ. Drugs effective in the treatment of migraine. In: Hardman JG, Gilman AG, Limbird LE (eds). The Pharmacological Basis of Therapeutics, vol 9. New York: McGraw-Hill; 1996; 487-502.